Abstract |
Growing data have recognized the significance of Response Gene to Complement (RGC)-32 in numerous tumour developments. Notwithstanding, the functional role and underlying mechanism of it in tongue squamous cell carcinoma (TSCC) remain enigmatic. Here, to identify the impact of RGC-32 in TSCC, its expression in multiple TSCC cells was measured and loss-of-function experiments in cell lines were performed to illuminate the function of it induced TSCC progression, via si- RNA knockdown, CCK-8, colony formation, wound-healing, transwell, flow cytometry and western blot assays. To clarify potential mechanism, expressions of hallmarks in epithelial-mesenchymal transition (EMT) process and PI3K/AKT signalling were assessed, and the upstream miR regulator of RGC-32 was predicted and verified by applying bioinformatic approaches and dual- luciferase reporter assay, respectively. Finally, the rescue experiments were applied to better elucidate the effect of miR-26b/RGC-32 axis in TSCC behaviours. As a result, RGC-32 was upregulated in TSCC cells and knocking down of it abrogated cell proliferation, trans-migration and invasion, whilst promoted apoptosis in TSCC, which was regulated through repressing EMT and inactivation of PI3K/AKT signalling. Subsequently, miR-26b was predicted and identified as an upstream regulator of RGC-32, and the pro-tumorigenic effect of RGC-32 was reversed by miR-26b overexpression. Collectively, our results demonstrated that RGC-32 facilitated TSCC progression, which was modulated by activations of PI3K/AKT pathway and EMT process, and reduction of its negative regulator of miR-26b. These findings highlight a novel role of miR-26b/RGC-32 axis in TSCC and underlying mechanism, encouraging a potent usage in TSCC treatment. SIGNIFICANCE OF THE STUDY: We first uncovered that Response Gene to Complement-32 played a significantly pro-tumorigenic role in tongue squamous cell carcinoma (TSCC), which was closely regulated by downregulation of miR-26b and activations of epithelial-mesenchymal transition process and PI3K/AKT signalling. These findings contribute to better understand the molecular mechanism in carcinogenesis of TSCC, and shed some light on promising strategy for TSCC therapeutics.
|
Authors | Zhong-Heng Yang, Juan Li, Wei-Zhi Chen, Fan-Shuang Kong |
Journal | Cell biochemistry and function
(Cell Biochem Funct)
Vol. 38
Issue 7
Pg. 943-954
(Oct 2020)
ISSN: 1099-0844 [Electronic] England |
PMID | 32325539
(Publication Type: Journal Article)
|
Copyright | © 2020 John Wiley & Sons Ltd. |
Chemical References |
- Antagomirs
- Cadherins
- Cell Cycle Proteins
- MIRN26A microRNA, human
- MicroRNAs
- Muscle Proteins
- Nerve Tissue Proteins
- RGCC protein, human
- RNA, Small Interfering
- Proto-Oncogene Proteins c-akt
|
Topics |
- Antagomirs
(metabolism)
- Cadherins
(metabolism)
- Carcinoma, Squamous Cell
(metabolism, pathology)
- Cell Cycle Proteins
(antagonists & inhibitors, genetics, metabolism)
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation
- Epithelial-Mesenchymal Transition
- Humans
- MicroRNAs
(antagonists & inhibitors, genetics, metabolism)
- Muscle Proteins
(antagonists & inhibitors, genetics, metabolism)
- Nerve Tissue Proteins
(antagonists & inhibitors, genetics, metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- RNA Interference
- RNA, Small Interfering
(metabolism)
- Signal Transduction
- Tongue Neoplasms
(metabolism, pathology)
- Up-Regulation
|